NCT00488878 Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
| NCT ID | NCT00488878 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Low Grade Ovarian Serous Adenocarcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2006-05-19 |
| Primary Completion | 2034-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2006-05-19 with a primary completion date of 2034-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.
Eligibility Criteria
Inclusion Criteria: * Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis: * Ovarian tumor of low malignant potential * Low-grade serous carcinoma of the ovary * Primary peritoneal tumor of low malignant potential * Low-grade serous carcinoma of the peritoneum * Psammocarcinoma
Contact & Investigator
David M Gershenson
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT00488878 clinical trial?
This trial is open to female participants only, studying Low Grade Ovarian Serous Adenocarcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00488878 currently recruiting?
Yes, NCT00488878 is actively recruiting participants. Contact the research team at lcnathan@mdanderson.org for enrollment information.
Where is the NCT00488878 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT00488878 clinical trial?
NCT00488878 is sponsored by M.D. Anderson Cancer Center. The principal investigator is David M Gershenson at M.D. Anderson Cancer Center. The trial plans to enroll 2,000 participants.